Skip to main content
Search
Main Navigation
Home
News
Current Index
Topics
Research leaders
Supplements
Further analysis
Client
services
About
×
Search category
Institutions
Countries/territories
Topics
Article
Search
Search
Search
Search
Time frame: 1 June 2025 - 30 May 2026
Institution search supports local language names.
(Examples: Universidad Autónoma de Madrid
,
筑波大学)
View the latest institution rankings
View the latest Country/territory rankings
View topics
Home
Articles
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201.
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201.
Journal:
Journal of Clinical Oncology
Published:
2025-07-12
DOI
:
10.1200/jco-25-00112
Affiliations:
32
Authors:
25
Go to article
Institutions
Authors
Share
Verastem, Inc., United States of America (USA)
2.000000
0.08
University of Virginia (UVA), United States of America (USA)
1.000000
0.04
Weill Cornell Medicine, United States of America (USA)
1.000000
0.04
OU Health Sciences Center (OUHSC), United States of America (USA)
1.000000
0.04
Barnes-Jewish Hospital, United States of America (USA)
1.000000
0.04
AdventHealth, United States of America (USA)
1.000000
0.04
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
1.000000
0.04
OSU Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), United States of America (USA)
1.000000
0.04
University Hospitals Leuven (UZ Leuven), Belgium
1.000000
0.04
Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Belgium
1.000000
0.04
University Hospital of Liege, Belgium
1.000000
0.04
Sansum Clinic, United States of America (USA)
1.000000
0.04
Northwest Cancer Specialists PC, United States of America (USA)
1.000000
0.04
Vall d'Hebron University Hospital (HUVH), ICS, Spain
1.000000
0.04
Florida Cancer Specialists and Research Institute (FCS), United States of America (USA)
1.000000
0.04
Yale University, United States of America (USA)
1.000000
0.04
Minnesota Oncology, United States of America (USA)
1.000000
0.04
H. Lee Moffitt Cancer Center & Research Institute, United States of America (USA)
1.000000
0.04
GTG-UK, United Kingdom (UK)
0.666667
0.03
University of Milano-Bicocca (UNIMIB), Italy
0.500000
0.02
IRCCS European Institute of Oncology (IEO), Italy
0.500000
0.02
CRUK Scotland Institute, United Kingdom (UK)
0.500000
0.02
The University of Edinburgh, United Kingdom (UK)
0.500000
0.02
Curie Institute, France
0.500000
0.02
Chimie et Biologie du Cancer (CBC), France
0.500000
0.02
Institut du Cancer de Montpellier (ICM), France
0.500000
0.02
ARCAGY-GINECO, France
0.500000
0.02
The Christie NHS Foundation Trust, United Kingdom (UK)
0.333333
0.01
The University of Manchester (UoM), United Kingdom (UK)
0.333333
0.01
The Royal Marsden NHS Foundation Trust, United Kingdom (UK)
0.333333
0.01
The Institute of Cancer Research (ICR), United Kingdom (UK)
0.333333
0.01
Interested in
Oncology and Carcinogenesis
?
News
News home
News
Comment
Data insights
Dataviz
Careers
Q+A
Archive
Current Index
Institution rankings
Institution benchmarking
Institution collaboration
Country/territory rankings
Country/territory benchmarking
Country/territory collaboration
Data visualizations
Articles
Research highlights
Data products survey
Topics
Topic explorer
Nature Index topics
Leading institutions by topic
Leading countries/territories by topic
Research leaders
Research leaders home
2026 Research Leaders
2025 Research Leaders
2024 Research Leaders
2023 Research Leaders
2022 Research Leaders
2021 Research Leaders
2020 Research Leaders
2019 Research Leaders
2018 Research Leaders
2017 Research Leaders
2016 Research Leaders
Supplements
Nature Index supplements
Further analysis
Author gender ratio
Applied sciences
Nature Strategy Reports
Client services
Client services
Advertising
Research management
Brochure
About
Mission statement
A brief guide to the Nature Index
How to use the Nature Index
FAQ
About Nature Research Intelligence Topics
Institutions A-Z
Glossary of terms
Follow us on Twitter
Follow us on Facebook